Use of dapagliflozin as an add-on to insulin therapy in patients with suboptimally controlled type 2 diabetes

Ítems similars

• Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus
  per: Tamez, Hector E., et al.
  Publicat: (2015)
• Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
  per: von Websky, Karoline, et al.
  Publicat: (2013)
• The use of metformin as an add-on therapy to insulin in the treatment of poorly controlled type 1 diabetes mellitus in adolescents
  per: Sikorskaya, Katsiaryna, et al.
  Publicat: (2021)
• Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study
  per: Lee, Seung-Hwan, et al.
  Publicat: (2021)
• Assessment of Dapagliflozin Effectiveness as Add-on Therapy for the Treatment of Type 2 Diabetes Mellitus in a Qatari Population
  per: Al AdAwi, Rana Moustafa, et al.
  Publicat: (2019)